Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma. - Leineweber CG; Rabehl M; Pietzner A; Rohwer N; Rothe M; Pech M; Sangro B; Sharma R; Verslype C; Basu B; Sengel C; Ricke J; et al. (Frontiers in pharmacology, 2024)